Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Seawon Meditech is a South Korea-based private medical device company focused on minimally invasive products for spine, pain management, regenerative medicine, vascular, joint, aesthetic, and personal healthcare applications. The company manufactures and exports interventional devices such as balloon kyphoplasty systems, epidural and steerable catheters, micro-endoscope systems, disc decompression products, and bone marrow cell concentration kits. Its portfolio is oriented toward procedural and device-based treatment rather than drug development, with a particular emphasis on spine and pain indications such as vertebral compression fractures, spinal stenosis, chronic back pain, and post-laminectomy syndrome. Seawon Meditech appears to operate commercially with products marketed internationally through a distributor network across multiple regions. The business is best characterized as a health-tech and medical device manufacturer rather than a biotech or pharmaceutical therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Seawon Meditech.